Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients

Birgit Edlich, Golo Ahlenstiel, Aintzane Zabaleta Azpiroz, Jonathan Stoltzfus, Mazen Noureddin, Elisavet Serti, Jordan J. Feld, T. Jake Liang, Yaron Rotman, Barbara Rehermann

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients'. Together they form a unique fingerprint.

Medicine & Life Sciences